TargetMol
CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent.
More Information
Supplier Page
TargetMol
CTX-0294885, a novel bisanilino pyrimidine, exhibits inhibitory activity against a broad range of kinases in vitro and is further developed into a Sepharose-supported kinase capture reagent.
More Information
Supplier Page
TargetMol
SB-431542(SB 431542) is a potent and selective inhibitor of ALK5 (IC50: 94 nM) and is also an inhibitor of ALK4 (IC50: 140 nM) and ALK7.
More Information
Supplier Page
TargetMol
SB-431542(SB 431542) is a potent and selective inhibitor of ALK5 (IC50: 94 nM) and is also an inhibitor of ALK4 (IC50: 140 nM) and ALK7.
More Information
Supplier Page
TargetMol
IBMX
200 mg
| 99.76%
TargetMol
IBMX
100 mg
| 99.76%
TargetMol
TargetMol
TargetMol
TargetMol